Tel Aviv Stock Exchange Ltd. TASE
TASE · İsrail · Finans
ILA 13.920,00+220,00 (+%1,61)
Piyasa kapalı· · ILA · Veriler gecikmeli olabilir
Fiyatlar gecikmeli olabilir ve yalnızca bilgilendirme amaçlıdır - yatırım tavsiyesi değildir.
Piyasa kapalı· · ILA · Veriler gecikmeli olabilir
Fiyatlar gecikmeli olabilir ve yalnızca bilgilendirme amaçlıdır - yatırım tavsiyesi değildir.
Temettüler dahil toplam getiri.
Fiyatın 50 ve 200 günlük hareketli ortalamalara göre konumu.
Makkler Adil Değer, finansal sağlık skoru, analist görüşü, benzer şirketler ve MakklerAI.
Government bond yields are biting into equity valuations and shaking up volatility, yet for global exchange and trading platform operators this storm can also mean more activity on their markets. You do not need to trade interest rates to feel the impact. Order flow, hedging, and portfolio reshuffles all run through these venues. This article unpacks that link and spotlights 3 stocks that look especially exposed to the current rate shock. The stocks highlighted below are only a small sample...
Tel-Aviv Stock Exchange (TASE:TASE) has been added to the FTSE All-World Index in USD, a shift that can draw fresh attention from global index trackers and institutional portfolios. The Tel-Aviv Stock Exchange share price has surged recently, with a 1-day share price return of 14.98% and a 30-day share price return of 28.29% taking it to ₪147.4. The 1-year total shareholder return of 97.09% alongside a very large 5-year total shareholder return near 10x points to strong, building momentum...
Teva Begins Trading Ordinary Shares Directly on the NYSE Teva Pharmaceutical Industries Ltd Begins Trading Ordinary Shares Directly on the NYSE, Marking a Milestone in its Pivot to Growth Strategy PARSIPPANY, N.J. and TEL AVIV, Israel, Sept. 14, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), a global biopharmaceutical company, today announced that its ordinary shares will begin trading today directly on the New York Stock Exchange (NYSE) completing the compan
Üçüncü taraf yayıncıların bu şirket hakkındaki son başlıkları; Makkler'in kendi editoryal içeriğinden ayrı tutulur ve dış kaynağa yönlendirir. Başlıkların doğruluğu ilgili yayıncının sorumluluğundadır.